Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a mass (lump or growth) in the pancreas that has been examined using a procedure called endoscopic ultrasound (a camera with sound waves), which may have included taking a small tissue or fluid sample
- People who have a mass in the pancreas that has been examined using a CT scan (with and/or without contrast dye), which may have included taking a sample of the mass or related lesions using an imaging-guided needle
- People who have been diagnosed with pancreatic adenocarcinoma (a specific type of pancreatic cancer) confirmed by laboratory analysis of tissue or cell samples
Who may not be able to join:
- People who have a pancreatic tumour that has been tested and found to be a type other than adenocarcinoma
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Barbara BOURNET, MD, PhD, University Hospital, Toulouse
Phone: (0)5 61 32 32 35
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Enrichment of prospective BACAP collection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.